These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

257 related items for PubMed ID: 11086023

  • 1. Adipose tissue is required for the antidiabetic, but not for the hypolipidemic, effect of thiazolidinediones.
    Chao L, Marcus-Samuels B, Mason MM, Moitra J, Vinson C, Arioglu E, Gavrilova O, Reitman ML.
    J Clin Invest; 2000 Nov; 106(10):1221-8. PubMed ID: 11086023
    [Abstract] [Full Text] [Related]

  • 2. Liver peroxisome proliferator-activated receptor gamma contributes to hepatic steatosis, triglyceride clearance, and regulation of body fat mass.
    Gavrilova O, Haluzik M, Matsusue K, Cutson JJ, Johnson L, Dietz KR, Nicol CJ, Vinson C, Gonzalez FJ, Reitman ML.
    J Biol Chem; 2003 Sep 05; 278(36):34268-76. PubMed ID: 12805374
    [Abstract] [Full Text] [Related]

  • 3. Troglitazone action is independent of adipose tissue.
    Burant CF, Sreenan S, Hirano K, Tai TA, Lohmiller J, Lukens J, Davidson NO, Ross S, Graves RA.
    J Clin Invest; 1997 Dec 01; 100(11):2900-8. PubMed ID: 9389757
    [Abstract] [Full Text] [Related]

  • 4. Diabetic KKAy mice exhibit increased hepatic PPARgamma1 gene expression and develop hepatic steatosis upon chronic treatment with antidiabetic thiazolidinediones.
    Bedoucha M, Atzpodien E, Boelsterli UA.
    J Hepatol; 2001 Jul 01; 35(1):17-23. PubMed ID: 11495036
    [Abstract] [Full Text] [Related]

  • 5. Up-regulation of peroxisome proliferator-activated receptors (PPAR-alpha) and PPAR-gamma messenger ribonucleic acid expression in the liver in murine obesity: troglitazone induces expression of PPAR-gamma-responsive adipose tissue-specific genes in the liver of obese diabetic mice.
    Memon RA, Tecott LH, Nonogaki K, Beigneux A, Moser AH, Grunfeld C, Feingold KR.
    Endocrinology; 2000 Nov 01; 141(11):4021-31. PubMed ID: 11089532
    [Abstract] [Full Text] [Related]

  • 6. Characterization of new oral antidiabetic agent CS-045. Studies in KK and ob/ob mice and Zucker fatty rats.
    Fujiwara T, Yoshioka S, Yoshioka T, Ushiyama I, Horikoshi H.
    Diabetes; 1988 Nov 01; 37(11):1549-58. PubMed ID: 3053303
    [Abstract] [Full Text] [Related]

  • 7. The novel hypoglycemic agent YM440 normalizes hyperglycemia without changing body fat weight in diabetic db/db mice.
    Shimaya A, Kurosaki E, Nakano R, Hirayama R, Shibasaki M, Shikama H.
    Metabolism; 2000 Mar 01; 49(3):411-7. PubMed ID: 10726922
    [Abstract] [Full Text] [Related]

  • 8. Troglitazone and related compounds: therapeutic potential beyond diabetes.
    Fujiwara T, Horikoshi H.
    Life Sci; 2000 Oct 06; 67(20):2405-16. PubMed ID: 11065164
    [Abstract] [Full Text] [Related]

  • 9. From fat-free mice, the skinny on diabetes.
    Gura T.
    Science; 1998 Oct 23; 282(5389):604. PubMed ID: 9841407
    [No Abstract] [Full Text] [Related]

  • 10. Insulin resistance and its treatment by thiazolidinediones.
    Lebovitz HE, Banerji MA.
    Recent Prog Horm Res; 2001 Oct 23; 56():265-94. PubMed ID: 11237217
    [Abstract] [Full Text] [Related]

  • 11. Efficacy and safety of troglitazone in the treatment of lipodystrophy syndromes.
    Arioglu E, Duncan-Morin J, Sebring N, Rother KI, Gottlieb N, Lieberman J, Herion D, Kleiner DE, Reynolds J, Premkumar A, Sumner AE, Hoofnagle J, Reitman ML, Taylor SI.
    Ann Intern Med; 2000 Aug 15; 133(4):263-74. PubMed ID: 10929166
    [Abstract] [Full Text] [Related]

  • 12. Troglitazone increases the number of small adipocytes without the change of white adipose tissue mass in obese Zucker rats.
    Okuno A, Tamemoto H, Tobe K, Ueki K, Mori Y, Iwamoto K, Umesono K, Akanuma Y, Fujiwara T, Horikoshi H, Yazaki Y, Kadowaki T.
    J Clin Invest; 1998 Mar 15; 101(6):1354-61. PubMed ID: 9502777
    [Abstract] [Full Text] [Related]

  • 13. Novel genes regulated by the insulin sensitizer rosiglitazone during adipocyte differentiation.
    Albrektsen T, Frederiksen KS, Holmes WE, Boel E, Taylor K, Fleckner J.
    Diabetes; 2002 Apr 15; 51(4):1042-51. PubMed ID: 11916924
    [Abstract] [Full Text] [Related]

  • 14. Differential effects of rexinoids and thiazolidinediones on metabolic gene expression in diabetic rodents.
    Singh Ahuja H, Liu S, Crombie DL, Boehm M, Leibowitz MD, Heyman RA, Depre C, Nagy L, Tontonoz P, Davies PJ.
    Mol Pharmacol; 2001 Apr 15; 59(4):765-73. PubMed ID: 11259621
    [Abstract] [Full Text] [Related]

  • 15. A new thiazolidinedione, NC-2100, which is a weak PPAR-gamma activator, exhibits potent antidiabetic effects and induces uncoupling protein 1 in white adipose tissue of KKAy obese mice.
    Fukui Y, Masui S, Osada S, Umesono K, Motojima K.
    Diabetes; 2000 May 15; 49(5):759-67. PubMed ID: 10905484
    [Abstract] [Full Text] [Related]

  • 16. Lipoatrophy, lipodystrophy, and insulin resistance.
    Ganda OP.
    Ann Intern Med; 2000 Aug 15; 133(4):304-6. PubMed ID: 10929174
    [No Abstract] [Full Text] [Related]

  • 17. Differential activation of peroxisome proliferator-activated receptor-gamma by troglitazone and rosiglitazone.
    Camp HS, Li O, Wise SC, Hong YH, Frankowski CL, Shen X, Vanbogelen R, Leff T.
    Diabetes; 2000 Apr 15; 49(4):539-47. PubMed ID: 10871190
    [Abstract] [Full Text] [Related]

  • 18. WY14,643, a peroxisome proliferator-activated receptor alpha (PPARalpha ) agonist, improves hepatic and muscle steatosis and reverses insulin resistance in lipoatrophic A-ZIP/F-1 mice.
    Chou CJ, Haluzik M, Gregory C, Dietz KR, Vinson C, Gavrilova O, Reitman ML.
    J Biol Chem; 2002 Jul 05; 277(27):24484-9. PubMed ID: 11994294
    [Abstract] [Full Text] [Related]

  • 19. [Thiazolidinediones: clinical data and perspectives].
    Blicklé JF.
    Diabetes Metab; 2001 Apr 05; 27(2 Pt 2):279-85. PubMed ID: 11452222
    [Abstract] [Full Text] [Related]

  • 20. Troglitazone inhibits atherosclerosis in apolipoprotein E-knockout mice: pleiotropic effects on CD36 expression and HDL.
    Chen Z, Ishibashi S, Perrey S, Osuga Ji, Gotoda T, Kitamine T, Tamura Y, Okazaki H, Yahagi N, Iizuka Y, Shionoiri F, Ohashi K, Harada K, Shimano H, Nagai R, Yamada N.
    Arterioscler Thromb Vasc Biol; 2001 Mar 05; 21(3):372-7. PubMed ID: 11231916
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.